Sugi Predict

Sugi Predict / Compounds / SCHEMBL1367348

SCHEMBL1367348

SCHEMBL1367348

CC(C)c1cnn2c(NCc3ccccc3F)cc(NC(CO)CCO)nc12

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK7 P50613 18/20 0.83
▸ CDK2 P24941 10/20 0.56
▸ CCNE1 P24864 8/20 0.56
▸ CCNH P51946 8/20 0.56
▸ CDK9 P50750 6/20 0.56
▸ CDK1 P06493 6/20 0.56
▸ CDK5 Q00535 6/20 0.56
▸ CDK4 P11802 4/20 0.56
▸ CDK6 Q00534 4/20 0.56
▸ CCNT1 O60563 3/20 0.56
▸ CDK8 P49336 3/20 0.56
▸ CCNB1 P14635 2/20 0.56
▸ CCND1 P24385 2/20 0.56
▸ INSRR P14616 1/20 0.56
▸ MAPK3 P27361 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ CSNK1A1 P48729 1/20 0.56
▸ DYRK1A Q13627 1/20 0.56
▸ MAPK15 Q8TD08 1/20 0.56
▸ CAMKK2 Q96RR4 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1367345 1.00 CDK7 (0.83) CDK7CDK2CCNE1CCNHCDK9
SCHEMBL1370025 1.00 CDK7 (0.83) CDK7CDK2CCNE1CCNHCDK9
SCHEMBL1368215 0.94 CDK7 (0.82) CDK7CDK2CCNE1CCNHCDK9
SCHEMBL12143356 0.92 CDK7 (0.79) CDK7CDK2CCNE1CCNHCDK9
SCHEMBL1366787 0.91 CDK7 (1.00) CDK7CDK2CCNE1CCNHCDK9
SCHEMBL1366786 0.91 CDK7 (1.00) CDK7CDK2CCNE1CCNHCDK9
SCHEMBL12143254 0.91 CDK7 (1.00) CDK7CDK2CCNE1CCNHCDK9
SCHEMBL12143397 0.90 CDK7 (0.73) CDK7CDK2CCNE1CCNHCDK9
SCHEMBL12143314 0.87 CDK7 (0.81) CDK7CDK2CCNE1CCNHCDK9
SCHEMBL12143292 0.87 CDK7 (0.81) CDK7CDK2CCNE1CCNHCDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8067424-B2 Selective inhibitors for cyclin-dependent kinases EMORY UNIVERSITY (US) 2011-11-29 — — US disclosed
US-8067424-B2 Selective inhibitors for cyclin-dependent kinases EMORY UNIVERSITY (US) 2011-11-29 — — US disclosed
US-8067424-B2 Selective inhibitors for cyclin-dependent kinases EMORY UNIVERSITY (US) 2011-11-29 — — US disclosed
US-20100261683-A1 Selective Inhibitors for Cyclin-Dependent Kinases EMORY UNIVERSITY 2010-10-14 — — US disclosed
US-20100261683-A1 Selective Inhibitors for Cyclin-Dependent Kinases EMORY UNIVERSITY 2010-10-14 — — US disclosed
US-20100261683-A1 Selective Inhibitors for Cyclin-Dependent Kinases EMORY UNIVERSITY 2010-10-14 — — US disclosed
WO-2008151304-A1 SELECTIVE INHIBITORS FOR CYCLIN-DEPENDENT KINASES EMORY UNIVERSITY (US) 2008-12-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261683-A1 Selective Inhibitors for Cyclin-Dependent Kinases CDK7, CCNK, CDK17 CDK7 1/4885CDK2 5/4885CCNE1 41/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback